Butyrate-mediated acquisition of chemoresistance by human colon cancer cells.
暂无分享,去创建一个
[1] G. Park,et al. Anti-Proliferative Effect of Naringenin through p38-Dependent Downregulation of Cyclin D1 in Human Colorectal Cancer Cells , 2015, Biomolecules & therapeutics.
[2] J. H. Lee,et al. Antitumor Effects of Fucoidan on Human Colon Cancer Cells via Activation of Akt Signaling , 2015, Biomolecules & therapeutics.
[3] So H. Kim,et al. Increased chemoresistance to paclitaxel in the MCF10AT series of human breast epithelial cancer cells. , 2015, Oncology reports.
[4] Agnieszka Gornowicz,et al. Cytotoxic activity of octahydropyrazin[2,1-a:5,4-a′]diisoquinoline derivatives in human breast cancer cells , 2014, Archives of Pharmacal Research.
[5] Pedro Gonçalves,et al. Butyrate and colorectal cancer: the role of butyrate transport. , 2013, Current drug metabolism.
[6] J. Turnay,et al. Resistance to butyrate impairs bile acid-induced apoptosis in human colon adenocarcinoma cells via up-regulation of Bcl-2 and inactivation of Bax. , 2012, Biochimica et biophysica acta.
[7] Wei Sun,et al. The Warburg effect dictates the mechanism of butyrate-mediated histone acetylation and cell proliferation. , 2012, Molecular cell.
[8] Robert Clarke,et al. Glucose-regulated protein 78 controls cross-talk between apoptosis and autophagy to determine antiestrogen responsiveness. , 2012, Cancer research.
[9] Guoxin Zhang,et al. Osteopontin Enhances the Expression and Activity of MMP-2 via the SDF-1/CXCR4 Axis in Hepatocellular Carcinoma Cell Lines , 2011, PloS one.
[10] P. Guilloteau,et al. From the gut to the peripheral tissues: the multiple effects of butyrate , 2010, Nutrition Research Reviews.
[11] E. Lam,et al. Butyrate-rich Colonic Microenvironment Is a Relevant Selection Factor for Metabolically Adapted Tumor Cells* , 2010, The Journal of Biological Chemistry.
[12] Zhiwei Wang,et al. Retracted: Down‐regulation of Jagged‐1 induces cell growth inhibition and S phase arrest in prostate cancer cells , 2006, International journal of cancer.
[13] S. Cole,et al. Multidrug resistance proteins: role of P-glycoprotein, MRP1, MRP2, and BCRP (ABCG2) in tissue defense. , 2005, Toxicology and applied pharmacology.
[14] M. Gorospe,et al. Acquisition of Resistance to Butyrate Enhances Survival after Stress and Induces Malignancy of Human Colon Carcinoma Cells , 2004, Cancer Research.
[15] G. Pagès,et al. Phosphorylation of Bim-EL by Erk1/2 on serine 69 promotes its degradation via the proteasome pathway and regulates its proapoptotic function , 2003, Oncogene.
[16] S. Cook,et al. Activation of the ERK1/2 Signaling Pathway Promotes Phosphorylation and Proteasome-dependent Degradation of the BH3-only Protein, Bim* , 2003, Journal of Biological Chemistry.
[17] E. Levy,et al. Butyrate induced Caco-2 cell apoptosis is mediated via the mitochondrial pathway , 2003, Gut.
[18] P. Wright,et al. Expression of p21Waf1/Cip1 and cyclin D1 is increased in butyrate-resistant HeLa cells. , 2001, The Journal of biological chemistry.
[19] D. Faller,et al. Butyrate-induced G1 arrest results from p21-independent disruption of retinoblastoma protein-mediated signals. , 1998, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.
[20] A. Jemal,et al. Cancer statistics, 2015 , 2015, CA: a cancer journal for clinicians.
[21] T. Gaschott,et al. Short-chain fatty acids and colon cancer cells: the vitamin D receptor--butyrate connection. , 2003, Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer.